iRhythm Finds $17M

San Francisco-based iRhythm Technologies said today that it has raised $17M in a Series E financing round. The company, which develops products for continuous monitoring of cardiac arrhythmia, said the funding was led by Novo A/S, and also included Norwest Venture Partners. The funding will go to grow its market, expand technology development, and other efforts at the company. iRhythm develops a small, wearable patch which monitors cardiac arrhythmia in patients. More information »